NeuroPace (NPCE) Receivables (2020 - 2026)

NeuroPace has reported Receivables for 7 years, with the latest figure at $14.9 million in Q2 2026.

• On a quarterly basis, Receivables rose 10.15% year-over-year to $14.9 million in Q2 2026; TTM through Jun 2026 was $14.9 million, a 10.15% increase from a year earlier, with the FY2025 full-year figure at $14.7 million, up 13.95% from the prior year.
• Receivables was $14.9 million for Q2 2026 at NeuroPace, up from $14.8 million in the prior quarter.
• The five-year high for Receivables was $15.4 million in Q1 2025, with the low at $7.5 million in Q4 2022.
• Average Receivables over 5 years is $11.7 million, with a median of $11.6 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2026: Receivables soared 64.58% in 2023, then retreated 4.19% in 2026.
• Over 5 years, Receivables stood at $7.5 million in 2022, then jumped by 64.58% to $12.3 million in 2023, then rose by 4.36% to $12.9 million in 2024, then rose by 0.66% to $12.9 million in 2025, then climbed by 15.41% to $14.9 million in 2026.
• The last three Receivables figures came in at $14.9 million (Q2 2026), $14.8 million (Q1 2026), and $12.9 million (Q4 2025), per Business Quant data.